Loading…
Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants
Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA‐S) levels are associated with remission of major depressive disorder by assessing scores on the 17‐Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment. Methods Plasma...
Saved in:
Published in: | Human psychopharmacology 2014-05, Vol.29 (3), p.280-286 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA‐S) levels are associated with remission of major depressive disorder by assessing scores on the 17‐Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment.
Methods
Plasma DHEA‐S levels in 24 patients diagnosed with major depressive disorder on the basis of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision) before and after antidepressant treatment, and 24 healthy, gender‐matched, and age‐matched controls were measured using a radioimmunoassay kit.
Results
Plasma DHEA‐S levels in patients were significantly higher than those in healthy controls. In patients who achieved remission after antidepressant treatment, plasma DHEA‐S levels significantly declined compared with the levels before treatment. A significant correlation was observed between changes in DHEA‐S levels and Absence of Depressive and Anxious Mood scores, which are calculated from the 2‐Item Structured Interview Guide for the Hamilton Depression rating as follows: severity of depressive mood and anxiety in patients before and after antidepressant treatment.
Conclusions
These findings suggest that plasma DHEA‐S levels can be used as a putative indicator of the state of remission in patients with major depressive disorder. Copyright © 2014 John Wiley & Sons, Ltd. |
---|---|
ISSN: | 0885-6222 1099-1077 |
DOI: | 10.1002/hup.2400 |